Studykik -

is a leading global patient recruitment and retention platform that bridges the gap between medical research and the people who need it most. Founded in 2014 and headquartered in Irvine, California, it has transformed the way clinical trials find and engage participants by leveraging a massive network of over 1,000 indication-specific patient communities. Key Features and Impact

Patients with any of the following: * Any type of cancer. * Any type of rare disease. * Asthma. * Atopic Dermatitis. How CRIO and StudyKIK Empower Clinical Research studykik

: The company has supported over 3,800 research sites and enrolled more than 5,400 protocols worldwide, making it a critical player in modern medical advancement. Why Participants Join Other Study Type Study Page - StudyKIK is a leading global patient recruitment and retention

: StudyKIK provides a one-stop platform for research sites to manage digital marketing, SMS texting, and global call centers, all aimed at finding qualified patients faster. * Any type of rare disease

: In 2021, StudyKIK was acquired by Syneos Health to bolster their decentralized clinical trial (DCT) capabilities, integrating cutting-edge search and telemedicine tools into the research process.

: The platform is designed to make clinical trials accessible to everyone, covering therapeutic areas ranging from common conditions like asthma and allergies to complex fields like oncology and rare diseases.